The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma
2019 · Molecular Therapy — Oncolytics · 20 citations
https://doi.org/10.1016/j.omto.2019.05.002
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
239
Citations
7
h-index
6
i10-index
Brynjar Mauseth is an academic researcher. The author has contributed to research in topics: Immunotherapy and Immune Responses & Cancer Research and Treatments & RNA Interference and Gene Delivery. The author has an h-index of 7, co-authored 19 publications.
https://doi.org/10.1016/j.omto.2019.05.002
https://doi.org/10.1038/s41598-021-86239-6
Click to start Chat